Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2005, p. 9897-9909, Vol. 25, No. 22
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.22.9897-9909.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
N. Colombié,1,3
P. Gallant,2
D. Cribbs,1 and
D. Morello1*
Centre de Biologie du Développement, CNRS UMR 5547, Université Paul Sabatier, 118 Rte. de Narbonne, 31062 Toulouse Cedex, France,1 Zoologisches Institut, Universität Zürich, Winterthurerstrasse 190, 8057 Zürich, Switzerland,2 Institut de Sciences et Technologies du Médicament de Toulouse, UMR 2587, CNRS-Pierre Fabre, 3 rue des Satellites, 31400 Toulouse, France3
Received 28 February 2005/ Returned for modification 8 April 2005/ Accepted 15 July 2005
The human c-myc proto-oncogene, implicated in the control of many cellular processes including cell growth and apoptosis, encodes three isoforms which differ in their N-terminal region. The functions of these isoforms have never been addressed in vivo. Here, we used Drosophila melanogaster to examine their functions in a fully integrated system. First, we established that the human c-Myc protein can rescue lethal mutations of the Drosophila myc ortholog, dmyc, demonstrating the biological relevance of this model. Then, we characterized a new lethal dmyc insertion allele, which permits expression of human c-Myc in place of dMyc and used it to compare physiological activities of these isoforms in whole-organism rescue, transcription, cell growth, and apoptosis. These isoforms differ both quantitatively and qualitatively. Most remarkably, while the small c-MycS form truncated for much of its N-terminal trans-activation domain efficiently rescued viability and cell growth, it did not induce detectable programmed cell death. Our data indicate that the main functional difference between c-Myc isoforms resides in their apoptotic properties and that the N-terminal region, containing the conserved MbI motif, is decisive in governing the choice between growth and death.
Present address: Gema Biotech S.A., Marcelo T. de Alvear 2289 1122, Buenos Aires, Argentina.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»